Biblio Discovery — Demo Discovery Service

39 results for "Simon R. Procter"

Showing 1–20 · 0.18 seconds · RSS

  1. Journal Article

    Cost-effectiveness analysis of maternal vaccination against Group B streptococcus in Japan

    Sumire Sorano; Simon R Procter; Anna C Seale

    Vaccine: X, Vol. 14 · 2023 · English · DOAJ Scopus

    Background: Group B Streptococcus (GBS) is a leading pathogen causing life-threatening bacterial infections in neonates (early- or late-onset) and infants, and is associated with preterm and stillbirth. Japan introduced national guidelines to reduce early-onset neonatal GBS disease, with universal…

  2. Journal Article Full text

    paramix: An R package for parameter discretisation in compartmental models, with application to calculating years of life lost.

    Lucy Goodfellow; Carl A B Pearson; Simon R Procter

    PLoS Computational Biology, Vol. 21 No. 9 · 2025 · English · DOAJ Scopus

    Compartmental infectious disease models are used to calculate disease transmission, estimate underlying rates, forecast future burden, and compare benefits across intervention scenarios. These models aggregate individuals into compartments, often stratified by characteristics to represent groups…

    Also available at: PLOS

  3. Journal Article

    Correspondence to: Estimating the full health and economic benefits of current and future influenza vaccines

    Naomi R. Waterlow; Simon R. Procter; Rosalind M. Eggo et al.

    BMC Medicine, Vol. 21 No. 1 · 2023 · English · DOAJ Scopus

    Abstract We recently published an article in BMC Medicine looking at the potential health and economic impact of paediatric vaccination using next-generation influenza vaccines in Kenya: a modelling study. In their commentary on our article, Lafond et al. highlight the potential importance of the…

  4. Journal Article

    Economic evaluation of prenatal GBS immunization in China: A modeling analysis

    Wenjing Ji; Jiaxi Du; Simon R. Procter et al.

    Human Vaccines & Immunotherapeutics, Vol. 21 No. 1 · 2025 · English · DOAJ Scopus

    Invasive Group B Streptococcus (GBS) infection is a fatal disease that causes a significant disease burden in young infants worldwide. GBS vaccines being developed are a potential means of preventing GBS; however, their cost-effectiveness in China is unknown. Using a decision analysis model, we…

  5. Journal Article Full text

    Estimation of country-level incidence of early-onset invasive Group B Streptococcus disease in infants using Bayesian methods

    Bronner P. Gonçalves; Simon R. Procter; Sam Clifford et al.

    PLOS Computational Biology, Vol. 17 No. 6 · 2021 · English · PLOS Scopus

    Neonatal invasive disease caused by Group B Streptococcus (GBS) is responsible for much acute mortality and long-term morbidity. To guide development of better prevention strategies, including maternal vaccines that protect neonates against GBS, it is necessary to estimate the burden of this…

    Also available at: DOAJ

  6. Journal Article Full text

    The benefits and risks of maternal RSV vaccination on mortality in South Africa: A modeling study

    Ayaka Monoi; Akira Endo; Simon R. Procter et al.

    PLOS Medicine, Vol. 23 No. 1 · 2026 · English · PLOS Scopus

    Background: Maternal respiratory syncytial virus (RSV) vaccine, RSV prefusion F protein vaccine (RSVpreF (Abrysvo)), was found to be safe and efficacious in the MATISSE trial. However, post-hoc stratified analyses identified an excess of preterm births in the intervention arm in two…

    Also available at: DOAJ

  7. Journal Article Full text

    Maternal immunisation against Group B Streptococcus: A global analysis of health impact and cost-effectiveness

    Simon R. Procter; Bronner P. Gonçalves; Proma Paul et al.

    PLOS Medicine, Vol. 20 No. 3 · 2023 · English · PLOS Scopus

    …at reasonable prices is likely to be a cost-effective intervention. Simon R Procter and colleagues explore the global health impact and cost-effectiveness of maternal immunisation against Group B Streptococcus. Why was this study done?: What did the researchers do and find?: What do these findings…

    Also available at: DOAJ

  8. Journal Article

    SARS-CoV-2 infection risk during delivery of childhood vaccination campaigns: a modelling study

    Simon R. Procter; Kaja Abbas; Stefan Flasche et al.

    BMC Medicine, Vol. 19 No. 1 · 2021 · English · DOAJ Scopus

    Abstract Background The COVID-19 pandemic has disrupted the delivery of immunisation services globally. Many countries have postponed vaccination campaigns out of concern about infection risks to the staff delivering vaccination, the children being vaccinated, and their families. The World Health…

  9. Journal Article

    Potential health and economic impact of paediatric vaccination using next-generation influenza vaccines in Kenya: a modelling study

    Naomi R. Waterlow; Sreejith Radhakrishnan; Jeanette Dawa et al.

    BMC Medicine, Vol. 21 No. 1 · 2023 · English · DOAJ Scopus

    Abstract Background Influenza is a major year-round cause of respiratory illness in Kenya, particularly in children under 5. Current influenza vaccines result in short-term, strain-specific immunity and were found in a previous study not to be cost-effective in Kenya. However, next-generation…

  10. Journal Article Full text

    What, how and who: Cost-effectiveness analyses of COVID-19 vaccination to inform key policies in Nigeria

    Francis J. Ruiz; Sergio Torres-Rueda; Carl A. B. Pearson et al.

    PLOS Global Public Health, Vol. 3 No. 3 · 2023 · English · PLOS Scopus

    While safe and efficacious COVID-19 vaccines have achieved high coverage in high-income settings, roll-out remains slow in sub-Saharan Africa. By April 2022, Nigeria, a country of over 200 million people, had only distributed 34 million doses. To ensure the optimal use of health resources…

    Also available at: DOAJ, DOAJ

  11. Journal Article

    Health impact and cost-effectiveness of vaccination using potential next-generation influenza vaccines in Thailand: a modelling study

    Mark Jit; Yot Teerawattananon; Ben S Cooper et al.

    BMJ Global Health, Vol. 9 No. 11 · 2024 · English · DOAJ Scopus

    Introduction Thailand was one of the first low- and middle-income countries to publicly fund seasonal influenza vaccines, but the lack of predictability in the timing of epidemics and difficulty in predicting the dominant influenza subtypes present a challenge for existing vaccines. Next-generation…

  12. Journal Article

    COVID-19 length of hospital stay: a systematic review and data synthesis

    Eleanor M. Rees; Emily S. Nightingale; Yalda Jafari et al.

    BMC Medicine, Vol. 18 No. 1 · 2020 · English · DOAJ Scopus

    Abstract Background The COVID-19 pandemic has placed an unprecedented strain on health systems, with rapidly increasing demand for healthcare in hospitals and intensive care units (ICUs) worldwide. As the pandemic escalates, determining the resulting needs for healthcare resources (beds, staff…

  13. Journal Article

    Importance of patient bed pathways and length of stay differences in predicting COVID-19 hospital bed occupancy in England

    Quentin J. Leclerc; Naomi M. Fuller; Ruth H. Keogh et al.

    BMC Health Services Research, Vol. 21 No. 1 · 2021 · English · DOAJ Scopus

    Abstract Background Predicting bed occupancy for hospitalised patients with COVID-19 requires understanding of length of stay (LoS) in particular bed types. LoS can vary depending on the patient’s “bed pathway” - the sequence of transfers of individual patients between bed types during a hospital…

  14. Journal Article

    Assessing the impacts of COVID-19 vaccination programme’s timing and speed on health benefits, cost-effectiveness, and relative affordability in 27 African countries

    Yang Liu; Simon R. Procter; Carl A. B. Pearson et al.

    BMC Medicine, Vol. 21 No. 1 · 2023 · English · DOAJ Scopus

    Abstract Background The COVID-19 vaccine supply shortage in 2021 constrained roll-out efforts in Africa while populations experienced waves of epidemics. As supply improves, a key question is whether vaccination remains an impactful and cost-effective strategy given changes in the timing of…